Ces radiol. 2014, 68(1):9-15

Whole body 3 Tesla magnetic resonance imagingOriginal article

Boris Kreuzberg, Jiří Ferda, Jan Kastner
Klinika zobrazovacích metod LF UK a FN, Plzeň

Aim: Evaluation of the experience with whole body magnetic resonance on 3T system.

Method: 279 examinations performed on 3T system (SKYRA, Siemens, Erlangen, Germany) performed during 36 months were assessed according indications, possibility of imaging of the bone marrow, organs of the abdomen and lungs, when the indications are multiple myeloma, lymphoma or the other tumors.

Results: The most frequent indication remains multiple myeloma (228), in 35 patients was performed lymphoma imaging with reached sufficient diagnostic imaging enabling assessment of the bone marrow, lymph nodes, lungs and parenchymatous organs. Diffusion weighted imaging on 3T is sufficient, but increases the imaging time significantly.

Conclusion: Whole body imaging on 3T MRI is fully diagnostic in the evaluation of staging or restaging in multiple myeloma, lymhomas or the other tumors.

Keywords: whole body imaging, three Tesla MRI, multiple myeloma, lymphoma staging
Grants and funding:

Podpořeno projektem Ministerstva zdravotnictví ČR Koncepční rozvoj výzkumné instituce 00669806 - FN Plzeň a Programem rozvoje vědních oborů Karlovy Univerzity (projekt P36).

Accepted: January 15, 2014; Published: March 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kreuzberg B, Ferda J, Kastner J. Whole body 3 Tesla magnetic resonance imaging. Ces radiol. 2014;68(1):9-15.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Machann J, Schlemmer H-P, Schick F. Ttechnical challenges and opportunities of whole-body magnetic resonance imaging at 3TPhysica Medica 2008; 24: 63-70. Go to original source... Go to PubMed...
    2. Akay S, Kocaoglu M, Emer O, Battal B, Arslan N. Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms. J Med Imaging Radiat Oncol 2013; 57(3): 274-282. Go to original source... Go to PubMed...
    3. Schmidt G, Dinter D, Reiser MF, Schoenberg SO. The uses and limitations of whole-body magnetic resonance imaging. Dtsch Arztebl Int 2010; 107(22): 383-389. Go to original source... Go to PubMed...
    4. Eichner R, Wörtler K, Essler M, et al. Symmetric multifocal bone marrow involvement diagnosed by whole-body magnetic resonance imaging in a patient with B lymphoblastic lymphoma. Ann Hematol 2013; 92(2): 277-278. Go to original source... Go to PubMed...
    5. Lin C, Luciani A, Itti E, et al. Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma. Eur Radiol 2010; 20(8): 2027-2038. Go to original source... Go to PubMed...
    6. De Paepe K, Bevernage C, De Keyzer F, et al. Whole-body diffusion-weighted magnetic resonance imaging at 3Tesla for early assessment of treatment response in non-Hodgkin lymphoma: a pilot study. Cancer Imaging 2013; 13: 53-62. Go to original source... Go to PubMed...
    7. Kwee TC, Fijnheer R, Ludwig I, et al. Whole-body magnetic resonance imaging, including diffusion-weighted imaging, for diagnosing bone marrow involvement in malignit lymphoma. Br J Haematol 2010; 149(4): 628-630. Go to original source... Go to PubMed...
    8. Lambregts DM, Maas M, Cappendijk VC, et al. Whole-body diffusion-weighted magnetic resonance imaging: current evidence in oncology and potential role in colorectal cancer staging. Eur J Cancer 2011; 47(14): 2107-2116. Go to original source... Go to PubMed...
    9. Li B, Li Q, Nie W, Liu S. Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis. Eur J Radiol 2014; 83(2): 338-344. Go to original source... Go to PubMed...
    10. Ferrari C, Minoia C, Asabella AN, et al. Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma. Hell J Nucl Med 2014; 17(Suppl 1): 40-49.
    11. Linton KD, Catto JW. Whole-body magnetic resonance imaging and prostate cancer metastases: a new gold standard of detection, but does it help us and at what cost? Eur Urol 2012; 62(1): 76-77. Go to original source... Go to PubMed...
    12. Venkitaraman R, Cook GJ, Dearnaley DP, et al. Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer. J Med Imaging Radiat Oncol 2009; 53(3): 241-247. Go to original source... Go to PubMed...
    13. Schmidt H, Brendle C, Schraml C, et al. Correlation ofsimultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F]fluoro-2-D-glucose positron emission tomography of pulmonary lesions in adedicated whole-body magnetic resonance/positron emission tomography system.Invest Radiol 2013; 48(5): 247-255. Go to original source... Go to PubMed...
    14. Merz M, Hielscher T, Wagner B, et al. Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma. Leukemia 2014 Feb 18. doi: 10.1038/leu.2014.75. [Epub ahead of print] PubMed PMID: 24535407. Go to original source... Go to PubMed...
    15. Hillengass J, Fechtner K, Weber MA, et al. Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol 2010; 28(9): 1606-1610. Go to original source... Go to PubMed...
    16. Heusner TA, Kuemmel S, Koeninger A, et al. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging. Eur J Nucl Med Mol Imaging 2010; 37(6): 1077-1786. Go to original source... Go to PubMed...
    17. Yi CA, Lee KS, Lee HY, Kim S, et al. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial. Cancer 2013; 119(10): 1784-1791. Go to original source... Go to PubMed...
    18. Puls R, Kuhn JP, Ewert R, Hosten N. Whole-body magnetic resonance imaging for staging of lung cancer. Front Radiat Ther Oncol 2010; 42: 46-54. Go to original source... Go to PubMed...
    19. Wu LM, Gu HY, Zheng J, et al. Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis. J Magn Reson Imaging 2011; 34(1): 128-135. Go to original source... Go to PubMed...
    20. Sakurai Y, Kawai H, Iwano S, et al. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer. J Med Imaging Radiat Oncol 2013; 57(3): 297-305. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content